IP Library Patent Application 13082260
Patent Application
App. No. 13/082,260

METHOD AND SYSTEMS FOR BUFFERING ANESTHETIC CARTRIDGES WITH BUFFERING SOLUTIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/082,260
Abstract

An anesthetic cartridge is adapted to receive a volume of buffer by displacing a plunger in one end of the anesthetic cartridge inwardly so that addition of the buffer volume will not displace the plunger excessively beyond the end of the cartridge body. By properly determining the amount of buffer volume required to raise the pH of the anesthetic to a target value, the degree of inward displacement of the plunger can be determined and the cartridge can be used with a system for delivering a precise amount of buffer solution having a known pH into the cartridge to raise its pH, just before the anesthetic is delivered to the patient.

Claims (25)

1 . A method for buffering an anesthetic in a cartridge having a septum at one end and a plunger at the other end, said method comprising:

determining a volume of buffer needed to adjust the pH of a volume of the anesthetic to a target value;

providing an anesthetic cartridge containing the volume of anesthetic wherein the plunger is set back from an end of the cartridge by a distance sufficient to allow the cartridge to receive the volume of buffer without displacing the plunger beyond the end of the cartridge; and

introducing the volume of buffer into the cartridge.

2 . A method as in claim 1 , wherein the cartridge is prepared at a central manufacturing facility and the cartridges are distributed to a plurality of local users, wherein the users inject the buffer.

3 . A method as in claim 2 , wherein the users inject the buffer prior to a procedure, in order to produce buffered anesthetic for use in the procedure.

4 . A method as in claim 3 , wherein at least a portion of the buffered anesthetic is injected into a patient within 2 minutes of introducing the buffer.

5 . A method as in claim 1 , wherein the anesthetic originally has a pH below 6.0 and the volume of buffer raises the pH of the buffered anesthetic to at least 7.0.

6 . A method as in claim 5 , wherein the volume of buffer increases the pH to at least 7.3.

7 . A method as in claim 1 , wherein the local anesthetic is an amide local anesthetic.

8 . A method as in claim 1 , wherein the local anesthetic is an amine local anesthetic.

9 . A method as in claim 1 , wherein the local anesthetic is lidocaine.

10 . A method as in claim 1 , wherein the local anesthetic is articaine.

11 . A method as in claim 1 , wherein the local anesthetic contains a vasoconstrictor.

12 . A method as in claim 11 , wherein the vasoconstrictor is epinephrine.

13 . A method as in claim 1 , wherein an internal volume of the anesthetic cartridge is in the range from 1.45 ml to 2.3 ml, the anesthetic volume is in the range from 1.15 ml to 2.2 ml, and the buffer volume is in the range from 0.1 ml to 0.35 ml.

14 . A system for preparing a buffered anesthetic, said system comprising:

an anesthetic cartridge having a septum at one end and a plunger at the other end, wherein said cartridge is filled with a volume of anesthetic; and

a buffer container holding a volume of buffer selected to raise the pH of the anesthetic to a target pH;

wherein the buffer container is adapted to transfer the buffer volume to the anesthetic cartridge and wherein the plunger is set back from an end of the anesthetic cartridge by a distance sufficient to allow the cartridge to receive the buffer volume without displacing the plunger beyond the end of the cartridge.

15 . A system as in claim 13 , wherein the anesthetic cartridge has an internal volume in the range from 1.45 ml to 2.3 ml, the anesthetic volume within the cartridge is in the range from 1.1 ml to 2.2 ml, and the buffer volume is in the range from 0.10 ml to 0.35 ml.

16 . A system as in claim 15 , wherein the buffer comprises a sodium bicarbonate solution having a nominal pH and an actual pH which is with ±0.1 of the nominal pH.

17 . An inventory of anesthetic cartridges comprising:

a plurality of identical containers each having a plunger at one end, a septum at other end, and being partially filled with an anesthetic solution;

wherein the plunger in each container is spaced away from the plunger end of the cartridge by a distance of at least 10% of the container length.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Dec 3, 2014
From: ONPHARMA INC
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 034524/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2011
From: STEPOVICH, MATTHEW J.; FALKEL, MICHAEL I.
To: ONPHARMA, INC.
Reel/Frame 026707/0272 →